Oppenheimer & CO Inc Clene Inc. Transaction History

Oppenheimer & CO Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.33 - $73.0 $825 - $182,500	-2,500 Reduced 7.81%	29,526 $83,000
Q2 2022 Aug 08, 2022	BUY	$2.1 - $4.12 $14,389 - $28,230	6,852 Added 27.22%	32,026 $81,000
Q1 2022 May 12, 2022	BUY	$2.42 - $4.42 $7,163 - $13,083	2,960 Added 13.32%	25,174 $99,000
Q4 2021 Feb 02, 2022	BUY	$3.95 - $7.53 $87,745 - $167,271	22,214 New	22,214 $91,000

230K

25K

Ticker CLNN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 63,502,000
Market Cap $273M
Description
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral scleros...

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Oppenheimer & CO Inc with notifications on news.